Market Highlights
The US melanoma market has been evaluated as fast growing market and it is expected that the market will continue to grow similarly in the near future. Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma, and others. About 98% of melanoma is localized in the US.
US melanoma market was about US$ 2.4 billion in 2015 and is expected to reach US$ 3.2 billion by 2023 at a CAGR of 8.3%.
Test the market data and market information presented through more than 25 market data tables and figures spread over 51 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “US Melanoma Market Research Report – Global Forecast to 2023.”
Get Sample Report: https://www.marketresearchfuture.com/sample_request/2950
US Melanoma Market Players:
Some of the key players in this market are: Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.
Regional Analysis:
Melanoma market in the US is divided into sates comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio.
In the US, California and Florida are key regions for Melanoma market. Large number of melanoma cases are found in this region. New York is third largest market after Florida. In the US the incidence of melanoma is found to be increasing due to indoor tanning. Tanning devices are used in spas, salons, hotels and sporting facilities. Tanning devices emit UV radiations thus increasing the risk of cancer. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. Government initiates to tackle this diseases are also important drivers for this market.
US Melanoma Market, By Type
US melanoma market has been segmented on the basis of type (superficial, nodular, lentigo maglina, acral, polypoid, desmoplastic), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).
Access Report Details @ https://www.marketresearchfuture.com/reports/us-melanoma-market-2950
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com